Identification of γ-Fagarine as a novel antiviral agent against respiratory virus (hMPV) infection
Human metapneumovirus (hMPV) causes significant upper and lower respiratory disease in all age groups worldwide. However, there is no licensed drugs or vaccine available against hMPV. γ-Fagarine, an alkaloid isolated from the root of zanthoxylum, has been reported to be effective in the treatment of...
Main Authors: | Jinhua Li, Yao Zhao, Ying Dai, Junning Zhao |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-10-01
|
Series: | Virus Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0168170223001855 |
Similar Items
-
Human Metapneumovirus (hMPV) Infection and MPV467 Treatment in Immunocompromised Cotton Rats <i>Sigmodon hispidus</i>
by: Kevin C. Yim, et al.
Published: (2023-02-01) -
Metapneumovirus humano (hMPV) asociado con exacerbación de asma aguda bronquial severa Human Metapneumovirus (hMPV) associated to severe bronchial asthmatic crisis
by: M. A. López, et al.
Published: (2006-09-01) -
Innate Immune Components That Regulate the Pathogenesis and Resolution of hRSV and hMPV Infections
by: Catalina A. Andrade, et al.
Published: (2020-06-01) -
Diversity in Glycosaminoglycan Binding Amongst hMPV G Protein Lineages
by: Penelope Adamson, et al.
Published: (2012-12-01) -
Clinical comparison of HMPV and RSV infections in hospitalised Malaysian children: A propensity score matched study
by: David Chun‐Ern Ng, et al.
Published: (2024-03-01)